The Cystotech team combines clinical insight with the operational expertise required to bring a medical device from research to real-world impact – improving outcomes for patients, supporting clinicians, and enabling more sustainable healthcare systems at scale.
Clinicians. Software engineers. Operators.
Built by a passionated and dedicated team.
TEAM
LEADERSHIP
Management team.
Anna Munk
Co-CEO
Operations, Regulatory Affairs
Certified urology nurse with 15+ years in bladder cancer care. Co-established the bladder cancer research unit at Aarhus University Hospital and former clinical trial manager.
Claus Hansen
Co-CEO
Strategic Partnerships, Commercialization, funding
Seasoned MedTech entrepreneur with 30+ years building and scaling medical device businesses within across a number of medical verticals. Worked as an independent distributor & managed EMEA distributors and headed direct commercial efforts in BeNeNord for several years. Two successful exits to major OEMs.
Jacob Elmose Jensen
Chief Medical Officer
Certified Urologist
Certified urologist with bladder cancer as primary clinical focus. Background in IT. Bridges clinical practices and product development.
Christian Lind Krog
Head of Development
Software development
Leading software development for Cystotech’s product portfolio, including testing, maintenance, and continuous improvement activities. Responsible for establishing and maintaining quality processes for software development, validation, and verification.
GOVERNANCE
Board of Directors
Lars Christian Lund
CHAIR
+20 years of commercial leadership experience from Denmark's leading MedTech companies, including senior roles at 3Shape as well as Ambu and Unomedical. Has a strong track record of scaling MedTech and AI-driven health technology companies internationally and is currently the CEO of Contour, a health-tech company focused on smarter, user-centric technology.
Nazarena Mazzaro
MEMBER
Senior MedTech executive with 20+ years across R&D, clinical development, regulatory affairs, and market access. Currently leading global R&D organizations in Sweden and Germany with full ownership of innovation strategy and portfolio. Proven board‑level leader with deep expertise in evidence‑driven innovation, governance, and scaling complex international teams.
Brian Hedegaard
MEMBER
Extensive experience in software engineering, quality management, and regulatory affairs for medical devices spanning 28+ years. Brings strategic regulatory insight to the board, backed by hands-on consulting experience and involvement as a MedTech angel investor.
Ole N.J. Jensen
MEMBER
Business Angel, Lead Investor and board member with extensive corporate experience in general management and strategy building critical public IT infrastructure. Primary focus is investing in companies that deliver a significant and positive impact on improving society benefits.
Mathias Brinch Lorenz
OBSERVER
Managing Partner at Delphinus Venture Capital, investing in founders solving real-world problems.
SUPPORT
Great partners have supported us on our journey so far.
